Bioreactors and Fermenters Market

Bioreactors and Fermenters Market (Product - Single-use Bioreactors and Multiple-use Bioreactors; Process - Fed Batch and Continuous Batch; End User - Biopharmaceutical Companies, CROs, and Academic and Research Institutes) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Global Bioreactors and Fermenters Market: Overview

The global bioreactors and fermenters market is estimated to expand at a CAGR of 12.2% during the forecast period, 2016­-2024. Thus, the market is estimated to gain a valuation of US$ 4,461.0 Mn by 2024.

Bioreactors and fermenters are widely utilized in the creation of appropriate environment for the microorganisms’ growth. Furthermore, these devices are also useful in driving biochemically active substances created by such organisms. Fermenters find application in the development and maintenance of fungal or bacterial cells in a controlled atmosphere. Bioreactors are the bigger versions of fermenters that are extensively used in the biopharmaceutical industry for the production of biologics including recombinant proteins, vaccines, and monoclonal antibodies.

A research report by Transparency Market Research (TMR) gives in-depth analysis of many crucial factors impacting the growth of the bioreactors and fermenters market. Thus, readers gain complete assessment on growth drivers, restraints, challenges, trends, and expansion opportunities in the market for bioreactors and fermenters.

Analysts of the study by TMR have performed the segmentation of the global bioreactors and fermenters market based on many important parameters such as product type, process, end-user, and region. In terms of product type, the market is classified into single-use bioreactors and multiple-use bioreactors. Moreover, the market is divided into continuous, fed batch, and batch on the basis of process.

bioreactors fermenters market 1

Increase in Cases of Diseases Creates Business Prospects in Market

Due to many factors such as unhealthy eating habits and sedentary lifestyles, there is rise in the number of health issues across the globe. This situation has resulted into increasing the requirement for personalized medicines, biologics, and drugs for orphan diseases, which is creating sales prospects in the global bioreactors and fermenters market. Moreover, the market is being driven by increase in demand for bioreactors and fermenters by varied end-users such as CROs, academic & research institutes, and biopharmaceutical companies.

Market Enterprises to Observe Lucrative Opportunities in North America and Europe

Various key regions supporting the growth of the global bioreactors and fermenters industry are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among all, Europe and North America are prominent regions holding 62% share of the global market for bioreactors and fermenters.

Some of the key factors making North America a dominating region include increasing use of single-use disposable bioreactors and rise in the adoption of advanced technologies in the bio-processing systems. Moreover, the regional market is prognosticated to experience higher growth prospects on the back of existence of many well-entrenched bioprocessing equipment producers and biopharmaceutical enterprises in the region.

Asia Pacific to Offer Promising Business Prospects and Expand at CAGR of 14.3% during Forecast Period

Asia Pacific is estimated to provide lucrative prospects in the bioreactors and fermenters market owing to many factors such as presence of several emerging economies in the region. Moreover, increase in investments by international level biopharmaceutical enterprises and contract manufacturers is likely to bode well with the regional market growth in the years to come.

Players Focus on Collaboration and Acquisition Strategies to Expand Their Businesses

The global bioreactors and fermenters market is fragmented in nature. Presence of many well-established companies represents intense level of competition in the market. Thus to sustain in this competition, enterprises are utilizing strategies such as collaborations and acquisitions.

Many players in the bioreactors and fermenters industry are increasing investments in R&D projects, which are focused on the introduction of break-through features in their existing products. Besides, several companies are focused on the launch of next-gen products. Such efforts are likely to generate promising business prospects in the bioreactors and fermenters market in the upcoming years.

Some of the key players operating in the global bioreactors and fermenters market include Applikon Biotechnology B.V., Finesse Solutions, Inc., Danaher Corporation, PBS Biotech, Inc., Eppendorf AG, Sartorius AG, GE Healthcare, ZETA Holding GmbH, PIERRE GUERIN TECHNOLOGIES, Solaris Biotechnology srl, Merck KGaA, and Thermo Fisher Scientific Inc.

The Bioreactors and Fermenters Market has been segmented as follows:

by Product

  • Single-use Bioreactors
  • Multiple-use Bioreactors

by Process

  • Fed batch
  • Continuous
  • Batch

by End User

  • Biopharmaceutical companies
  • CROs
  • Academic & Research Institutes

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • U.A.E.
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions

What is the total market worth of bioreactors and fermenters market?

Bioreactors and fermenters market is estimated to gain a valuation of US$ 4,461.0 Mn by 2024

What is the anticipated CAGR of the bioreactors and fermenters market in the forecast period?

Bioreactors and fermenters market is estimated to expand at a CAGR of 12.2% during the forecast period, 2016-2024

What are the key driving factors for the growth of the bioreactors and fermenters market?

Bioreactors and fermenters market is driven by increased prevalence of chronic diseases

Which region is expected to project the highest market share in the global bioreactors and fermenters market?

Asia Pacific is estimated to provide lucrative prospects in the bioreactors and fermenters market owing to many factors such as presence of several emerging economies in the region

Who are the key players in the global bioreactors and fermenters market?

Key players operating in the global bioreactors and fermenters market include Applikon Biotechnology B.V., Finesse Solutions, Inc., Danaher Corporation, PBS Biotech, Inc., Eppendorf AG, Sartorius AG, GE Healthcare

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Bioreactors and Fermenters Market

    4. Market Overview
         4.1. Introduction
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunity
         4.4. Global Bioreactors and Fermenters Market Analysis and Forecasts, 2016–2024
                4.4.1. Market Volume Projections
         4.5. Bioreactors and Fermenters Market - Global Supply Demand Scenario
         4.6. Porter’s Five Force Analysis
         4.7. Value Chain Analysis
                4.7.1. List of active market participants 
         4.8. Market Outlook

    5. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Product 
         5.1. Introduction & Definition
         5.2. Key Findings / Developments
         5.3. Key Trends
         5.4. Market Value Forecast By Product
                5.4.1. Single-use bioreactors
                5.4.2. Multi-use bioreactors
         5.5. Market Attractiveness By Product 

    6. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Process 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Key Trends
         6.4. Market Value Forecast By Process
                6.4.1. Fed batch
                6.4.2. Continuous
                6.4.3. Batch
         6.5. Market Attractiveness By Process 

    7. Global Bioreactors and Fermenters Market Analysis and Forecasts, By End-User 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Key Trends
         7.4. Market Value Forecast By End-User 
                7.4.1. Biopharmaceutical companies
                7.4.2. CROs
                7.4.3. Academic & Research Institutes
         7.5. Market Attractiveness By End-User 

    8. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Region
         8.1. Key Findings
         8.2. Market Value Forecast By Region
                8.2.1. North America 
                8.2.2. Europe 
                8.2.3. Asia Pacific 
                8.2.4. Latin America 
                8.2.5. Middle East and Africa 
         8.3. Market Attractiveness By Country/Region

    9. North America Bioreactors and Fermenters Market Analysis and Forecast
         9.1. Introduction
                9.1.1. Key Findings
                9.1.2. Key Trends
         9.2. Market Value Forecast By Product 
                9.2.1. Single-use bioreactors
                9.2.2. Multi-use bioreactors
         9.3. Market Value Forecast By Process 
                9.3.1. Fed batch
                9.3.2. Continuous
                9.3.3. Batch
         9.4. Market Value Forecast By End-User 
                9.4.1. Biopharmaceutical companies
                9.4.2. CROs
                9.4.3. Academic & Research Institutes
         9.5. Market Value Forecast By Country 
                9.5.1. U.S.
                9.5.2. Canada
         9.6. Market Attractiveness Analysis 

    10. Europe Bioreactors and Fermenters Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
                10.1.2. Key Trends
         10.2. Market Value Forecast By Product 
                10.2.1. Single-use bioreactors
                10.2.2. Multi-use bioreactors
         10.3. Market Value Forecast By Process 
                10.3.1. Fed batch
                10.3.2. Continuous
                10.3.3. Batch
         10.4. Market Value Forecast By End-User , 2014–2024
                10.4.1. Biopharmaceutical companies
                10.4.2. CROs
                10.4.3. Academic & Research Institutes
         10.5. Market Value Forecast By Country , 2014–2024
                10.5.1. Germany 
                10.5.2. France 
                10.5.3. U.K. 
                10.5.4. Rest of Europe
         10.6. Market Attractiveness Analysis 

    11. Asia Pacific Bioreactors and Fermenters Market Analysis and Forecast
         11.1. Introduction
                11.1.1. Key Findings
                11.1.2. Key Trends
         11.2. Market Value Forecast By Product 
                11.2.1. Single-use bioreactors
                11.2.2. Multi-use bioreactors
         11.3. Market Value Forecast By Process 
                11.3.1. Fed batch
                11.3.2. Continuous
                11.3.3. Batch
         11.4. Market Value Forecast By End-User 
                11.4.1. Biopharmaceutical companies
                11.4.2. CROs
                11.4.3. Academic & Research Institutes
         11.5. Market Value Forecast By Country 
                11.5.1. Japan 
                11.5.2. China 
                11.5.3. India 
                11.5.4. Australia 
                11.5.5. Rest of Asia Pacific
         11.6. Market Attractiveness Analysis 

    12. Latin America Bioreactors and Fermenters Market Analysis and Forecast
         12.1. Introduction
                12.1.1. Key Findings
                12.1.2. Key Trends
         12.2. Market Value Forecast By Product 
                12.2.1. Single-use bioreactors
                12.2.2. Multi-use bioreactors
         12.3. Market Value Forecast By Process 
                12.3.1. Fed batch
                12.3.2. Continuous
                12.3.3. Batch
         12.4. Market Value Forecast By End-User 
                12.4.1. Biopharmaceutical companies
                12.4.2. CROs
                12.4.3. Academic & Research Institutes
         12.5. Market Value Forecast By Country 
                12.5.1. Brazil 
                12.5.2. Mexico 
                12.5.3. Rest of Latin America
         12.6. Market Attractiveness Analysis 

    13. Middle East and Africa Bioreactors and Fermenters Market Analysis and Forecast
         13.1. Introduction
                13.1.1. Key Findings
                13.1.2. Key Trends
         13.2. Market Value Forecast By Product 
                13.2.1. Single-use bioreactors
                13.2.2. Multi-use bioreactors
         13.3. Market Value Forecast By Process 
                13.3.1. Fed batch
                13.3.2. Continuous
                13.3.3. Batch
         13.4. Market Value Forecast By End-User 
                13.4.1. Biopharmaceutical companies
                13.4.2. CROs
                13.4.3. Academic & Research Institutes
         13.5. Market Value Forecast By Country 
                13.5.1. Saudi Arabia 
                13.5.2. South Africa 
                13.5.3. Rest of MEA
         13.6. Market Attractiveness Analysis 

    14. Competition Landscape
         14.1. Market Player – Competition Matrix (By Tier and Size of companies)
         14.2. Market Share Analysis By Company (2015)
         14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                14.3.1. Applikon Biotechnology B.V. 
                         14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.1.2. Business Overview
                         14.3.1.3. Product Portfolio 
                         14.3.1.4. Financial Overview 
                         14.3.1.5. SWOT Analysis 
                         14.3.1.6. Strategic overview
                14.3.2. Danaher Corporation
                         14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.2.2. Business Overview
                         14.3.2.3. Product Portfolio 
                         14.3.2.4. Financial Overview 
                         14.3.2.5. SWOT Analysis 
                         14.3.2.6. Strategic overview
                14.3.3. Eppendorf AG
                         14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.3.2. Business Overview
                         14.3.3.3. Product Portfolio 
                         14.3.3.4. Financial Overview 
                         14.3.3.5. SWOT Analysis 
                         14.3.3.6. Strategic overview 
                14.3.4. Finesse Solutions, Inc. 
                         14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.4.2. Business Overview
                         14.3.4.3. Product Portfolio 
                         14.3.4.4. Financial Overview 
                         14.3.4.5. SWOT Analysis 
                         14.3.4.6. Strategic overview
                14.3.5. GE Healthcare
                         14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.5.2. Business Overview
                         14.3.5.3. Product Portfolio 
                         14.3.5.4. Financial Overview 
                         14.3.5.5. SWOT Analysis 
                         14.3.5.6. Strategic overview
                14.3.6. Merck KGaA
                         14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.6.2. Business Overview
                         14.3.6.3. Product Portfolio 
                         14.3.6.4. Financial Overview 
                         14.3.6.5. SWOT Analysis 
                         14.3.6.6. Strategic overview 
                14.3.7. PBS Biotech, Inc.
                         14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.7.2. Business Overview
                         14.3.7.3. Product Portfolio 
                         14.3.7.4. Financial Overview 
                         14.3.7.5. SWOT Analysis 
                         14.3.7.6. Strategic overview
                14.3.8. PIERRE GUERIN TECHNOLOGIES
                         14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.8.2. Business Overview
                         14.3.8.3. Product Portfolio 
                         14.3.8.4. Financial Overview 
                         14.3.8.5. SWOT Analysis 
                         14.3.8.6. Strategic overview
                14.3.9. Sartorius AG
                         14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.9.2. Business Overview
                         14.3.9.3. Product Portfolio 
                         14.3.9.4. Financial Overview 
                         14.3.9.5. SWOT Analysis 
                         14.3.9.6. Strategic overview
                14.3.10. SOLARIS BIOTECHNOLOGY srl
                         14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.10.2. Business Overview
                         14.3.10.3. Product Portfolio 
                         14.3.10.4. Financial Overview 
                         14.3.10.5. SWOT Analysis 
                         14.3.10.6. Strategic overview
                14.3.11. Thermo Fisher Scientific Inc
                         14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.11.2. Business Overview
                         14.3.11.3. Product Portfolio 
                         14.3.11.4. Financial Overview 
                         14.3.11.5. SWOT Analysis 
                         14.3.11.6. Strategic overview 
                14.3.12. ZETA Holding GmbH
                         14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                         14.3.12.2. Business Overview
                         14.3.12.3. Product Portfolio 
                         14.3.12.4. Financial Overview 
                         14.3.12.5. SWOT Analysis 
                         14.3.12.6. Strategic overview

    List of Tables

    Table 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product Type, 2016–2024
    Table 02: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process Type, 2016–2024
    Table 03: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 04: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Region, 2016–2024
    Table 05: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
    Table 06: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
    Table 07: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 08: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
    Table 09: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
    Table 10: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
    Table 11: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 12: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
    Table 13: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
    Table 14: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
    Table 15: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 16: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
    Table 17: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
    Table 18: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
    Table 19: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 20: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
    Table 21: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
    Table 22: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
    Table 23: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
    Table 24: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024

    List of Figures

    Figure 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
    Figure 02: Global Bioreactors and Fermenters Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 03: Global Single-use Bioreactors Market Revenue (US$ Mn), 2015-2024
    Figure 04: Global Multiple-use Bioreactors Market Revenue, US$ Mn, 2015–2024
    Figure 05: Bioreactors and Fermenters Market Attractiveness Analysis By Product Type
    Figure 06: Global Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 07: Fed batch Bioreactors Market Revenue, US$ Mn, 2014–2024
    Figure 08: Global Continuous Process Bioreactors Market Revenue, US$ Mn, 2014–2024
    Figure 09: Global Batch Process Bioreactors Market Revenue, US$ Mn, 2014–2024
    Figure 10: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Process Type
    Figure 11: Global Bioreactors and Fermenters Market Value Share Analysis By End users, 2016 and 2024
    Figure 12: Global Biopharmaceutical companies Market Revenue (US$ Mn), 2016–2024
    Figure 13: Global CROs Market Revenue (US$ Mn), 2016–2024
    Figure 14: Global Academic & Research Institutes Market Revenue (US$ Mn), 2016–2024
    Figure 15: Bioreactors and Fermenters Market Attractiveness Analysis, by End user
    Figure 16: Global Bioreactors and Fermenters Market Analysis By Region, 2016 and 2024
    Figure 17: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Region Type
    Figure 18: North America Bioreactors and Fermenters  Market Size (US$ Mn) Forecast, 2016–2024
    Figure 19: North America Market Attractiveness Analysis By Country
    Figure 20: North America Bioreactors and Fermenters Market Value Share Analysis By Product Type, 2016 and 2024
    Figure 21: North America Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 22: North America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
    Figure 23: North America Market Value Share Analysis By Country, 2016 and 2024
    Figure 24: North America Market Attractiveness Analysis, by Product 
    Figure 25: North America Market Attractiveness Analysis, by Process
    Figure 26: North America Market Attractiveness Analysis, by End User
    Figure 27: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
    Figure 28: Europe Market Attractiveness Analysis, by Country
    Figure 29: Europe Market Value Share Analysis By Product Type, 2016 and 2024
    Figure 30: Europe Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 31: Europe Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
    Figure 32: Europe Market Value Share Analysis, by Country, 2016 and 2024
    Figure 33: Europe Market Attractiveness Analysis, by Product
    Figure 34: Europe Market Attractiveness Analysis, by Process
    Figure 35: Europe Market Attractiveness Analysis, by End User
    Figure 36: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
    Figure 37: Asia Pacific Market Attractiveness Analysis, by Country
    Figure 38: Asia Pacific Market Value Share Analysis By Product Type, 2016 and 2024
    Figure 39: Asia Pacific Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 40: Asia Pacific Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
    Figure 41: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
    Figure 42: Asia Pacific Market Attractiveness Analysis, by Product 
    Figure 43: Asia Pacific Market Attractiveness Analysis, by Process
    Figure 44: Asia Pacific Market Attractiveness Analysis, by End User
    Figure 45: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
    Figure 46: Latin America Market Attractiveness Analysis, by Country
    Figure 47: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
    Figure 48: Latin America Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 49: Latin America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
    Figure 50: Latin America Market Value Share Analysis, by Country, 2016 and 2024
    Figure 51: Latin America Market Attractiveness Analysis, by Product 
    Figure 52: Latin America Market Attractiveness Analysis, by Process
    Figure 53: Latin America Market Attractiveness Analysis, by End User
    Figure 54: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
    Figure 55: Middle East and Africa Market Attractiveness Analysis, by Country
    Figure 56: Middle East and Africa Market Value Share Analysis By Product Type, 2016 and 2024
    Figure 57: Middle East and Africa Market Value Share Analysis By Process Type, 2016 and 2024
    Figure 58: Middle East and Africa Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
    Figure 59: Middle East and Africa Market Value Share Analysis, by Country, 2016 and 2024
    Figure 60: Middle East and Africa Market Attractiveness Analysis, by Product 
    Figure 61: Middle East and Africa Market Attractiveness Analysis, by Process
    Figure 62: Middle East and Africa Market Attractiveness Analysis, by End User
    Figure 63: Global Bioreactors and Fermenters Market Share Analysis By Company (2015)

Copyright © Transparency Market Research, Inc. All Rights reserved